NEW THERAPY OFFERS HOPE FOR BONE MARROW CANCER

Published:2019-05-03


A new therapy developed by Chinese researchers to treat bone marrow cancer has completed its first phase of clinical trials with a response rate of 90 percent.


The high response rate suggests the therapy might significantly raise the five-year survival rate of patients with multiple myeloma, which currently stands at 50.7 percent.

SITE MAP

World Time

  • SENEGAL | DAKAR:04.10 03:00

  • NIGERIA | LAGOS:04.10 04:00

  • EGYPT | CAIRO:04.10 05:00

  • UAE | DUBAI:04.10 07:00

  • SRI LANKA | COLOMBO:04.10 08:30

  • SINGAPORE:04.10 11:00

  • ENGLAND | LONDON:04.10 04:00

  • RUSSIA | MOSCOW:04.10 07:00

  • CHINA | BEIJING:04.10 11:00

  • AMERICA | Los Angels:04.09 20:00

  • AMERICA | New York:04.09 23:00

  • BRAZIL | San Paulo:04.10 00:00